Home » Topics » Conferences

Conferences
RSS

New Lilly compounds LY-314177 and LY-311912 active against influenza A infections in mice

Sep. 29, 1999

Ondansetron effectively controls tardive dyskinesia and improves symptoms of psychosis

Sep. 29, 1999

Duloxetine safety and pharmacokinetics determined in healthy volunteers

Sep. 29, 1999

Clinical candidate selected by Wakunaga from series of antibacterial 8-methylquinolones

Sep. 29, 1999

J-110441: a broad-spectrum carbapenem-derived beta-lactamase inhibitor designed at Banyu

Sep. 29, 1999

IntraDose featured in several ECCO 10 presentations; clinical results consistently positive

Sep. 29, 1999

Further efforts in the area of 2-pyridone antibacterials described by Abbott at ICAAC

Sep. 29, 1999

ECCO 10 presentation for a novel VEGF receptor TK inhibitor

Sep. 29, 1999

Novel natriuretic peptide is a candidate for treating CHF

Sep. 29, 1999

Conivaptan effectively and safely reverses hyponatremia in patients with CHF

Sep. 29, 1999

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...